5-((3-Amidobenzyl)oxy)nicotinamides as SIRT2 Inhibitors: A Study of Constrained Analogs
SIRT2 is a member of NAD<sup>+</sup>-dependent sirtuins and its inhibition has been proposed as a promising therapeutic approach for treating human diseases, including neurodegenerative diseases, cancer, and infections. Expanding SIRT2 inhibitors based on the 3-aminobenzyloxy nicotinamid...
Main Authors: | Teng Ai, Daniel J. Wilson, Liqiang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/22/7655 |
Similar Items
-
The Emerging Role of SIRT7 in Glucose and Lipid Metabolism
by: Kazuya Yamagata, et al.
Published: (2023-12-01) -
SIRT7 and hepatic lipid metabolism
by: Bor Luen eTang
Published: (2015-01-01) -
The Role of Sirtuin 6 in the Deacetylation of Histone Proteins as a Factor in the Progression of Neoplastic Disease
by: Marzena Baran, et al.
Published: (2023-12-01) -
Virtual Screening Combined with Enzymatic Assays to Guide the Discovery of Novel SIRT2 Inhibitors
by: Naomi Scarano, et al.
Published: (2023-05-01) -
Sirtuins Modulation: A Promising Strategy for HIV-Associated Neurocognitive Impairments
by: Izchel Figarola-Centurión, et al.
Published: (2022-01-01)